These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31441705)

  • 1. Antibiotic Resistance in Community-Acquired Intra-Abdominal Infections: Diabetes Mellitus as a Risk Factor.
    Núñez SA; Lacal V; Núñez J; Serruto G; Zárate MS; Verón MT
    Surg Infect (Larchmt); 2020 Feb; 21(1):62-68. PubMed ID: 31441705
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment.
    Silva-Nunes J; Cardoso T
    BMC Infect Dis; 2019 Nov; 19(1):980. PubMed ID: 31752716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of active microorganisms and antibiotic susceptibility in community-acquired intraabdominal infections in children.
    Tunay H; Tun AA; Boyac EO; Kesli R; Demırturk N
    Ann Ital Chir; 2023; 94():289-294. PubMed ID: 37530061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
    Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
    Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections.
    Liu L; Ni Y
    BMC Infect Dis; 2018 Nov; 18(1):584. PubMed ID: 30453893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis.
    Grau S; Lozano V; Valladares A; Cavanillas R; Xie Y; Nocea G
    Appl Health Econ Health Policy; 2015 Aug; 13(4):369-79. PubMed ID: 25761545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and microbiological characteristics of complicated intra-abdominal infection in Colombia: a multicenter study].
    Vallejo M; Cuesta DP; Flórez LE; Correa A; Llanos CE; Isaza B; Vanegas S; Osorio J; Casanova L; Villegas MV
    Rev Chilena Infectol; 2016 Jun; 33(3):261-7. PubMed ID: 27598273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections.
    Chong YP; Bae IG; Lee SR; Chung JW; Jun JB; Choo EJ; Moon SY; Lee MS; Jeon MH; Song EH; Lee EJ; Park SY; Kim YS
    PLoS One; 2015; 10(4):e0119956. PubMed ID: 25910171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.
    Lau YJ; Chen YH; Huang CT; Lee WS; Liu CY; Liu JW; Liu HD; Lee YJ; Chen CW; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2012 Feb; 45(1):1-6. PubMed ID: 22244019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Susceptibility of Microorganisms Isolated from Patients with Intraabdominal Infection in Korea: a Multicenter Study.
    Yoon YK; Kim J; Moon C; Lee MS; Hur J; Lee H; Kim SW
    J Korean Med Sci; 2019 Dec; 34(47):e309. PubMed ID: 31808326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Anti-Enterococcal Therapy for Intra-Abdominal Infection.
    Zhang J; Yu WQ; Chen W; Wei T; Wang CW; Zhang JY; Zhang Y; Liang TB
    Surg Infect (Larchmt); 2021 Mar; 22(2):131-143. PubMed ID: 32471332
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011.
    Hawser S; Hoban DJ; Badal RE; Bouchillon SK; Biedenbach D; Hackel M; Morrissey I
    J Chemother; 2015 Feb; 27(2):67-73. PubMed ID: 24548089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?
    Hennessy SA; Shah PM; Guidry CA; Davies SW; Hranjec T; Sawyer RG
    Surg Infect (Larchmt); 2015 Aug; 16(4):396-400. PubMed ID: 26069990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
    Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
    Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    Koksal I; Yilmaz G; Unal S; Zarakolu P; Korten V; Mulazimoglu L; Tabak F; Mete B; Oguz VA; Gulay Z; Alp E; Badal R; Lob S
    J Antimicrob Chemother; 2017 May; 72(5):1364-1372. PubMed ID: 28122913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013.
    Chang YT; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Barry W; Xu Y; Chen YH; Hsueh PR
    Int J Antimicrob Agents; 2017 Jun; 49(6):734-739. PubMed ID: 28435019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.